About Quantumdx group limited
Quantumdx Group Limited: Revolutionizing Multiplex Diagnostics for the Real World
Quantumdx Group Limited is a leading biotechnology company that specializes in developing and commercializing innovative diagnostic solutions. The company's mission is to revolutionize multiplex diagnostics for the real world by providing accurate, reliable, and affordable testing solutions that can be used anywhere, anytime.
Founded in 2008 by Jonathan O'Halloran and Elaine Warburton, Quantumdx has grown into a global leader in the field of molecular diagnostics. The company's cutting-edge technology enables rapid and accurate detection of infectious diseases, genetic disorders, cancer biomarkers, and other health conditions.
Quantumdx's flagship product is Q-POC™ - a portable diagnostic device that can perform multiple tests simultaneously using just a single sample. Q-POC™ uses microfluidic technology to isolate DNA or RNA from biological samples such as blood or saliva. The extracted genetic material is then amplified using polymerase chain reaction (PCR) to detect specific targets with high sensitivity and specificity.
Q-POC™ has several advantages over traditional laboratory-based testing methods. It requires minimal sample preparation time and can deliver results within 30 minutes. It also eliminates the need for expensive equipment or specialized training, making it ideal for use in resource-limited settings such as rural clinics or field hospitals.
In addition to Q-POC™, Quantumdx offers a range of other products and services tailored to meet the needs of different customers. These include:
1) Q-SIGHT® - A digital PCR platform that enables absolute quantification of nucleic acid targets with high precision.
2) Q-LAMP® - A loop-mediated isothermal amplification (LAMP) assay that provides rapid detection of infectious diseases such as tuberculosis (TB), malaria, HIV/AIDS.
3) Custom Assay Development - Quantumdx offers custom assay development services to help researchers design assays specific to their needs.
Quantumdx has a strong track record of innovation and has received numerous awards and accolades for its groundbreaking work. In 2020, the company was awarded a grant from the Bill & Melinda Gates Foundation to develop a rapid COVID-19 test using Q-POC™ technology.
Quantumdx is headquartered in Newcastle upon Tyne, UK, with additional offices in the US and Asia. The company has a global network of distributors and partners that help bring its products to market worldwide.
In conclusion, Quantumdx Group Limited is at the forefront of revolutionizing multiplex diagnostics for the real world. Its innovative products and services have the potential to transform healthcare by providing accurate, reliable, and affordable testing solutions that can be used anywhere, anytime. With its cutting-edge technology and strong commitment to innovation, Quantumdx is poised to make a significant impact on global health in the years ahead.